Please login to the form below

Not currently logged in
Email:
Password:

GRI

This page shows the latest GRI news and features for those working in and with pharma, biotech and healthcare.

Novo spends $800m to buy biotech and 'glucose responsive insulin' tech

Novo spends $800m to buy biotech and 'glucose responsive insulin' tech

Ziylo could help it stay ahead in key insulin franchise. Novo Nordisk is aiming to develop the world’s first glucose responsive insulin (GRI) by acquiring UK biotech start-up Ziylo.

Latest news

  • Takeda offers €520m for stem cell firm TiGenix Takeda offers €520m for stem cell firm TiGenix

    TiGenix’ board is backing the takeover deal, which values the company at 520m (around $630m), and two major shareholders - Gri-Cel and Grifols - have already said they will tender their shares.

  • No man is an island

    Perhaps the most high-profile example of these is the Global Reporting Initiative (GRI), which now has 50 pharmaceutical and biotech companies among its 1, 000-plus registered organisations.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

The biggest problems facing humanity today are health-related, and the health of people, animals and our planet are inextricably linked. ...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics